CORDIS · 775987 · H2020
IEM17 Innovative Enterprise Malta 2017
Coordinator: SPECIAL INTEREST TRAVEL LIMITED (MT)
Innovative Enterprise / Malta 2017 / 31st May - 3rd June
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €350k awarded to the consortium. The project runs over approximately 0.5 years from 2017-03-01 to 2017-08-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from MT
see all →- TargetMI — A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial Infarction101114924 · HORIZON · €4.0M
- GREEN TALENT — GREEN TALENT – Building Capacity and Partnerships for Systemic Solutions to the Climate and Biodiversity Crises101217375 · HORIZON · €3.0M
- PRI-SCI-NET — Networking Primary Science Educators as a means to provide training and professional development in Inquiry Based Teaching266647 · FP7 · €2.8M
- VENTURES THRIVE — Deeptech startup support programme to facilitate ventures thriving in the European Widening area101073762 · HORIZON · €2.0M
- TerraForm — The rise and fall of Maltese terraced landscapes101171158 · HORIZON · €2.0M
- TRANSIT — TRANSITion to sustainable future through training and education101075747 · HORIZON · €2.0M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the CSA funding scheme.
- What is the EU contribution?
- The European Commission contributes €350k toward a total project budget of €350k.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-IBA-ARF-IEW-2017.
- Who coordinates the project?
- The project is coordinated by SPECIAL INTEREST TRAVEL LIMITED (MT).
- What is the project timeline?
- The project runs from 2017-03-01 to 2017-08-31 — approximately 0.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 775987.